Mariner Independent Advisor Network’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-12,085
Closed -$1.82M 514
2021
Q1
$1.82M Sell
12,085
-1,198
-9% -$190K 0.09% 220
2020
Q4
$2.01M Buy
13,283
+656
+5% +$93.8K 0.11% 197
2020
Q3
$1.71M Buy
+12,627
New +$1.71M 0.14% 164
2020
Q2
Sell
-13,328
Closed -$1.41M 342
2020
Q1
$1.41M Sell
13,328
-24
-0.2% -$2.76K 0.13% 170
2019
Q4
$1.6M Sell
13,352
-652
-5% -$72.7K 0.12% 197
2019
Q3
$1.38M Sell
14,004
-1,064
-7% -$111K 0.11% 209
2019
Q2
$1.65M Sell
15,068
-1,211
-7% -$129K 0.12% 179
2019
Q1
$1.82M Sell
16,279
-1,190
-7% -$131K 0.15% 151
2018
Q4
$1.79M Buy
+17,469
New +$1.85M 0.16% 146
2018
Q3
Sell
-19,495
Closed -$2.14M 251
2018
Q2
$2.14M Sell
19,495
-32,103
-62% -$3.43M 0.38% 62
2018
Q1
$5.51M Buy
51,598
+17,316
+51% +$1.92M 0.34% 63
2017
Q4
$3.66M Sell
34,282
-5,849
-15% -$625K 0.38% 71
2017
Q3
$4.46M Sell
40,131
-1,296
-3% -$139K 0.73% 32
2017
Q2
$4.28M Buy
41,427
+10,794
+35% +$1.06M 0.61% 52
2017
Q1
$3M Sell
30,633
-16,653
-35% -$1.59M 0.36% 46
2016
Q4
$4.18M Buy
47,286
+1,449
+3% +$132K 0.68% 47
2016
Q3
$4.42M Buy
+45,837
New +$4.36M 0.63% 46
2015
Q1
Sell
-15,270
Closed -$1.54M 115
2014
Q4
$1.54M Buy
15,270
+4,830
+46% +$469K 0.72% 34
2014
Q3
$952K Buy
10,440
+1,662
+19% +$146K 0.5% 40
2014
Q2
$752K Buy
+8,778
New +$692K 0.37% 54

Other funds holding IBB

Mariner Independent Advisor Network's IBB Position: Q2 2021 in Review

Mariner Independent Advisor Network sold out of iShares Biotechnology ETF (IBB) in Q2 2021, closing a stake of 12,085 shares — an estimated $1.82M sold.

Mariner Independent Advisor Network first reported a position in IBB in Q2 2014 and held it in 20 quarters. The position peaked at $5.51M in Q1 2018. 863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

  • Mariner Independent Advisor Network reported no remaining iShares Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
  • Mariner Independent Advisor Network sold 12,085 iShares Biotechnology ETF shares in Q2 2021, an estimated $1.82M.
  • Mariner Independent Advisor Network first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 20 quarters.
  • Mariner Independent Advisor Network's iShares Biotechnology ETF position peaked at $5.51M in Q1 2018.
  • 863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on Mariner Independent Advisor Network's 13F filing for Q2 2021, filed 10 Aug 2021.